AURO LABORATORIES
Back to Cashflow Statement
|
AURO LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹18 Cr | ₹19 Cr | ₹-8.18 Cr | ₹9.79 Cr | ₹-0.46 Cr |
What is the latest Cash Flow from Financing Activities ratio of AURO LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹19 Cr |
| Mar2023 | ₹-8.18 Cr |
| Mar2022 | ₹9.79 Cr |
| Mar2021 | ₹-0.46 Cr |
How is Cash Flow from Financing Activities of AURO LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | -7.37 | |
| Mar2024 | ₹19 Cr | Positive | |
| Mar2023 | ₹-8.18 Cr | Negative | |
| Mar2022 | ₹9.79 Cr | Positive | |
| Mar2021 | ₹-0.46 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AURO LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AURO LABORATORIES | ₹164.3 Cr | -0% | -8.6% | 13.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,647.0 Cr | 0.1% | -0.4% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹157,862.0 Cr | -1.1% | -7.1% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,846.0 Cr | 0.2% | -4.5% | 30.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,720.0 Cr | 0.2% | -4% | 6% | Stock Analytics | |
| CIPLA | ₹98,795.9 Cr | 0% | -9.1% | -18.5% | Stock Analytics | |
AURO LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AURO LABORATORIES | -0% |
-8.6% |
13.3% |
| SENSEX | -3.5% |
-12.5% |
-6.5% |
You may also like the below Video Courses